Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 399 followers

Latest posts

Last updated 8 minutes ago

As BridgeBio's Attruby launch accelerates, CEO shrugs off recent EU pricing pressure fears

8 minutes ago

When BridgeBio presented its quarterly report on Tuesday, it laid out expectations...

Charles River sells manufacturing and discovery businesses to fulfill promised pivot

40 minutes ago

After promising to sell off 7% of its business back in November...

To reach consumers interested in GLP-1s, audio is ‘dramatically underutilized’: SiriusXM survey

about 1 hour ago

In developing media plans to reach the GLP-1-interested consumer, audio advertising may...

Gilead paints clearer picture of next-gen HIV tablet's prowess with results from 2 late-stage studies

about 1 hour ago

The company unveiled detailed results from its pair of late-stage Artistry trials...

Sanofi assists Boston’s World Cup plans with play for local engagement

about 3 hours ago

Sanofi has kicked off its preparations for the 2026 World Cup by...

How Evinova is Integrating AI into Clinical Development to Bring Big Impact to Big Pharma

about 3 hours ago

As pharma sponsors continually assesses how to integrate AI into their ways...

After 230% deal size explosion, China is no longer the 'bargain basement' for biopharma licensing: analyst

about 4 hours ago

The average upfront value for a licensing deal between a Western biopharma...

With Texas site, Novartis rounds out radiopharma production plans amid $23B US investment blitz

about 5 hours ago

Novartis is wasting little time sketching out the radiopharmaceutical details of its...

15 states sue RFK Jr. and CDC, challenging new childhood vaccine recommendations

about 6 hours ago

A coalition of 15 states is filing a lawsuit against Robert F...

GenEdit rewrites identity, emerging as BreezeBio with $60M for genetic medicine R&D

about 8 hours ago

GenEdit is sailing toward the clinic with a new name and fresh...

Novo to knock down Ozempic, Wegovy list prices next year, but self-pay channels unaffected

about 24 hours ago

Amid efforts on several fronts to improve the affordability of its GLP-1...

BioMarin pulls hemophilia gene therapy Roctavian, taking $240M hit after divestiture efforts flounder

1 day ago

Just three months after further scaling back its support for the struggling...